Enhancing off-nucleos(t)ide analogue outcome predictions in chronic hepatitis B with time-varying hepatitis B core-related antigen

Ítems similars

• Distinct patterns of serum hepatitis B core-related antigen during the natural history of chronic hepatitis B
  per: Zhan-Qing Zhang, et al.
  Publicat: (2017-12-01)
• Emerging Diagnostic Tools to Decide When to Discontinue Nucleos(t)ide Analogues in Chronic Hepatitis B
  per: Margarita Papatheodoridi, et al.
  Publicat: (2020-02-01)
• Hepatitis B Virus Reactivation upon Immunosuppression: Is There a Role for Hepatitis B Core-Related Antigen in Patients with Immune-Escape Mutants? A Case Report
  per: Gian Paolo Caviglia, et al.
  Publicat: (2021-11-01)
• Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-neegative chronic hepatitis B: A multicentre cohort study
  per: Milan J. Sonneveld, et al.
  Publicat: (2023-08-01)
• Hepatitis B Core-Related Antigen as Surrogate Biomarker of Intrahepatic Hepatitis B Virus Covalently-Closed-Circular DNA in Patients with Chronic Hepatitis B: A Meta-Analysis
  per: Gian Paolo Caviglia, et al.
  Publicat: (2021-01-01)